APA引用形式

Davies, M. J., Merton, K., Vijapurkar, U., Yee, J., & Qiu, R. (2017). Efficacy and safety of canagliflozin in patients with type 2 diabetes based on history of cardiovascular disease or cardiovascular risk factors: A post hoc analysis of pooled data. Cardiovasc Diabetol.

シカゴスタイル引用形

Davies, Michael J., Katherine Merton, Ujjwala Vijapurkar, Jacqueline Yee, , Rong Qiu. "Efficacy and Safety of Canagliflozin in Patients With Type 2 Diabetes Based On History of Cardiovascular Disease or Cardiovascular Risk Factors: A Post Hoc Analysis of Pooled Data." Cardiovasc Diabetol 2017.

MLA引用形式

Davies, Michael J., et al. "Efficacy and Safety of Canagliflozin in Patients With Type 2 Diabetes Based On History of Cardiovascular Disease or Cardiovascular Risk Factors: A Post Hoc Analysis of Pooled Data." Cardiovasc Diabetol 2017.

警告: この引用は必ずしも正確ではありません.